310 related articles for article (PubMed ID: 22359067)
41. [Current differential diagnosis of hypereosinophilic syndrome].
Dinić-Uzurov V; Lalosević V; Milosević I; Urosević I; Lalosević D; Popović S
Med Pregl; 2007; 60(11-12):581-6. PubMed ID: 18666600
[TBL] [Abstract][Full Text] [Related]
42. Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case report.
Granjo E; Lima M; Lopes JM; Dória S; Orfão A; Ying S; Barata LT; Miranda M; Cross NC; Bain BJ
Acta Haematol; 2002; 107(2):108-12. PubMed ID: 11919392
[TBL] [Abstract][Full Text] [Related]
43. Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review.
Nanagas VC; Kovalszki A
Clin Rev Allergy Immunol; 2019 Oct; 57(2):194-212. PubMed ID: 30003499
[TBL] [Abstract][Full Text] [Related]
44. [Disorders with eosinophilia, treatment of hypereosinophilic syndrome].
Borbényi Z
Orv Hetil; 2005 May; 146(18 Suppl 1):911-6. PubMed ID: 15921304
[TBL] [Abstract][Full Text] [Related]
45. Hypereosinophilic syndrome: an update.
Wilkins HJ; Crane MM; Copeland K; Williams WV
Am J Hematol; 2005 Oct; 80(2):148-57. PubMed ID: 16184589
[TBL] [Abstract][Full Text] [Related]
46. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
La Starza R; Specchia G; Cuneo A; Beacci D; Nozzoli C; Luciano L; Aventin A; Sambani C; Testoni N; Foppoli M; Invernizzi R; Marynen P; Martelli MF; Mecucci C
Haematologica; 2005 May; 90(5):596-601. PubMed ID: 15921374
[TBL] [Abstract][Full Text] [Related]
47. Response of Complex Undefined Hypereosinophilic Syndrome to Treatment with Imatinib.
Yılmaz İ; Kaynar L; Tutar N; Pala Ç; Canöz Ö; Yıldırım A; Büyükoğlan H; Gülmez İ
Turk Thorac J; 2016 Jul; 17(3):118-121. PubMed ID: 29404138
[TBL] [Abstract][Full Text] [Related]
48. How I treat hypereosinophilic syndromes.
Klion AD
Blood; 2015 Aug; 126(9):1069-77. PubMed ID: 25964669
[TBL] [Abstract][Full Text] [Related]
49. [The hypereosinophilic syndrome: case report].
Mikołajczyk K; Zaba R; Walkowiak B; Grzybowski G; Samborski W
Ann Acad Med Stetin; 2006; 52 Suppl 2():65-9. PubMed ID: 17471838
[TBL] [Abstract][Full Text] [Related]
50. [Hypereosinophilic syndromes: pathogenic and therapeutic up-to-date].
Kahn JE; Grandpeix-Guyodo C; Ackermann F; Charles P; Legrand F; Blétry O
Rev Med Interne; 2010 Apr; 31(4):268-76. PubMed ID: 20303627
[TBL] [Abstract][Full Text] [Related]
51. Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome.
Stone RM; Gilliland DG; Klion AD
Semin Oncol; 2004 Apr; 31(2 Suppl 6):12-7. PubMed ID: 15175999
[TBL] [Abstract][Full Text] [Related]
52. [The Hypereosinophilic Syndromes in Childhood].
Leu T; Simon HU; Hebestreit H; Kunzmann S
Klin Padiatr; 2015 Nov; 227(6-7):308-13. PubMed ID: 26267413
[TBL] [Abstract][Full Text] [Related]
53. Chronic eosinophilic leukemia and hypereosinophilic syndromes. Proposal for classification, literature review, and report of a case with a unique chromosomal abnormality.
Oliver JW; Deol I; Morgan DL; Tonk VS
Cancer Genet Cytogenet; 1998 Dec; 107(2):111-7. PubMed ID: 9844604
[TBL] [Abstract][Full Text] [Related]
54. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
Garg A; Duggal L; Aggarwal S; Jain N
J Assoc Physicians India; 2006 Nov; 54():883-6. PubMed ID: 17249259
[TBL] [Abstract][Full Text] [Related]
55. Hypereosinophilic syndrome, chronic eosinophilic leukemia, and mast cell disease.
Pardanani A; Verstovsek S
Cancer J; 2007; 13(6):384-91. PubMed ID: 18032976
[TBL] [Abstract][Full Text] [Related]
56. Cough in hypereosinophilic syndrome: case report and literature review.
Xie J; Zhang J; Zhang X; Zhang Q; Chung KF; Wang C; Lai K
BMC Pulm Med; 2020 Apr; 20(1):90. PubMed ID: 32293378
[TBL] [Abstract][Full Text] [Related]
57. Idiopathic hypereosinophilic syndrome associated with cutaneous infarction and deep venous thrombosis.
Narayan S; Ezughah F; Standen GR; Pawade J; Kennedy CT
Br J Dermatol; 2003 Apr; 148(4):817-20. PubMed ID: 12752146
[TBL] [Abstract][Full Text] [Related]
58. Current Approach to Diagnosis and Management of Pulmonary Eosinophilic Syndromes: Eosinophilic Pneumonias, Eosinophilic Granulomatosis with Polyangiitis, and Hypereosinophilic Syndrome.
Sergew A; Fernández Pérez ER
Semin Respir Crit Care Med; 2016 Jun; 37(3):441-56. PubMed ID: 27231866
[TBL] [Abstract][Full Text] [Related]
59. The hypereosinophilic syndromes: still more heterogeneity.
Gleich GJ; Leiferman KM
Curr Opin Immunol; 2005 Dec; 17(6):679-84. PubMed ID: 16214314
[TBL] [Abstract][Full Text] [Related]
60. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
Schwartz LB; Sheikh J; Singh A
Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]